Exhibit
10.2


 


REGISTRATION
RIGHTS AGREEMENT


 


BY
AND BETWEEN


 


INTELLIGENT
BIO SOLUTIONS INC.


 


THE
SELLERS LISTED ON ANNEX A HERETO


 


Dated
as of December 21, 2022


 




    	 



    	 



    

 


TABLE
OF CONTENTS


 


	 	Page
	ARTICLE
    I	 
	 	 
	Resale
    Shelf Registration	 
	 	 
	Section
    1.1 Resale Shelf Registration Statement	3
	Section
    1.2 Effectiveness Period	3
	Section
    1.3 Subsequent Shelf Registration Statement	4
	Section
    1.4 Supplements and Amendments	4
	Section
    1.5 Subsequent Holder Notice	4
	Section
    1.6 Underwritten Offering	5
	Section
    1.7 Take-Down Notice	6
	Section
    1.8 Piggyback Registration	6
	 	 
	ARTICLE
    II	 
	 	 
	Additional
    Provisions Regarding Registration Rights	 
	 	 
	Section
    2.1 Registration Procedures	7
	Section
    2.2 Suspension	10
	Section
    2.3 Expenses of Registration	10
	Section
    2.4 Information by Holders	10
	Section
    2.5 Rule 144 Reporting	11
	Section
    2.6 Plan of Distribution and Legal Counsel.	12
	Section
    2.7 Lockup	12
	 	 
	ARTICLE
    III	 
	 	 
	Indemnification	 
	 	 
	Section
    3.1 Indemnification by Company	12
	Section
    3.2 Indemnification by Holders	13
	Section
    3.3 Notification	13
	Section
    3.4 Contribution	14
	Section
    3.5 Survival	14
	 	 
	ARTICLE
    IV	 
	 	 
	Transfer
    and Termination of Registration Rights	 
	 	 
	Section
    4.1 Transfer of Registration Rights	14
	Section
    4.2 Termination of Registration Rights	15
	 	 
	ARTICLE
    V	 
	 	 
	Miscellaneous	 
	 	 
	Section
    5.1 Amendments and Waivers	15
	Section
    5.2 Extension of Time, Waiver, Etc.	15
	Section
    5.3 Assignment	15
	Section
    5.4 Counterparts	15
	Section
    5.5 Entire Agreement; No Third Party Beneficiary	15
	Section
    5.6 Governing Law; Jurisdiction	15
	Section
    5.7 Specific Enforcement	16
	Section
    5.8 Waiver of Jury Trial	16
	Section
    5.9 Notices	16
	Section
    5.10 Severability	17
	Section
    5.11 Expenses	17


 




    	2



    	 



    

 


REGISTRATION
RIGHTS AGREEMENT


 


This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of December 21, 2022 by and among INTELLIGENT
BIO SOLUTIONS INC., a Delaware corporation (the “Company”), the sellers listed on Annex A hereto (and together with
their successors and any Person that becomes a party hereto pursuant to Section 4.1, the “Sellers”). Capitalized
terms that are used but not defined elsewhere herein are defined in Exhibit A.


 


WHEREAS,
the Company and the Sellers are parties to that certain Securities Purchase Agreement, dated as of December 21, 2022 (the “Purchase
Agreement”), pursuant to which, each Seller will receive (i) shares of Series D Convertible Preferred Stock of the Company,
par value $0.01 per share (the “Company Convertible Preferred Stock”), which are convertible into common stock of
the Company, par value $0.01 per share (“Common Stock”), subject to the Conversion Approval and Reverse Split Approval,
and (ii) warrants to purchase Common Stock that are exercisable on or after the date that is six (6) months following the date of issuance
and which have a term of exercise equal to five (5) years from the initial exercise date (“Warrants”);


 


WHEREAS,
as a condition to the obligations of the Company and the Sellers under the Purchase Agreement, the Company and the Sellers are entering
into this Agreement for the purpose of granting certain registration and other rights to the Sellers.


 


NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, the receipt and sufficiency of which
are hereby acknowledged, the parties to this Agreement hereby agree as follows:


 


Article
I


 


Resale
Shelf Registration


 


Section
1.1 Resale Shelf Registration Statement. Subject to the other applicable provisions of this Agreement, the Company shall use its
commercially reasonable efforts to prepare and file, no later than the later of (a) the 30th calendar day following the Conversion Approval
Date and (b) the 30th calendar day following the Reverse Split Approval Date (such date, the “Filing Date”) , a registration
statement covering the sale or distribution from time to time by the Holders, on a delayed or continuous basis pursuant to Rule 415 of
the Securities Act, of all of the Registrable Securities on Form S-3 (except if the Company is not then eligible to register for resale
the Registrable Securities on Form S-3, then such registration shall be on another appropriate form and shall provide for the registration
of such Registrable Securities for resale by the Holders in accordance with any reasonable method of distribution elected by the Sellers)
(the “Resale Shelf Registration Statement”) and shall use its commercially reasonable efforts to cause such Resale
Shelf Registration Statement to be declared effective by no later than the thirtieth calendar day following the Filing Date (it being
agreed that the Resale Shelf Registration Statement shall be an automatic shelf registration statement that shall become effective upon
filing with the SEC pursuant to Rule 462(e) if Rule 462(e) is available to the Company).


 


Section
1.2 Effectiveness Period. Once declared effective, the Company shall, subject to the other applicable provisions of this Agreement,
use its commercially reasonable efforts to cause the Resale Shelf Registration Statement to be continuously effective and usable until
such time as there are no longer any Registrable Securities (the “Effectiveness Period”).


 




    	3



    	 



    

 


Section
1.3 Subsequent Shelf Registration Statement. If any Shelf Registration Statement ceases to be effective under the Securities Act
for any reason at any time during the Effectiveness Period, the Company shall use its commercially reasonable efforts to as promptly
as is reasonably practicable cause such Shelf Registration Statement to again become effective under the Securities Act (including obtaining
the prompt withdrawal of any order suspending the effectiveness of such Shelf Registration Statement), and shall use its commercially
reasonable efforts to as promptly as is reasonably practicable amend such Shelf Registration Statement in a manner reasonably expected
to result in the withdrawal of any order suspending the effectiveness of such Shelf Registration Statement or file an additional registration
statement (a “Subsequent Shelf Registration Statement”) for an offering to be made on a delayed or continuous basis
pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holders thereof of all securities that are
Registrable Securities as of the time of such filing. If a Subsequent Shelf Registration Statement is filed, the Company shall use its
commercially reasonable efforts to (a) cause such Subsequent Shelf Registration Statement to become effective under the Securities Act
as promptly as reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration Statement shall
be an automatic shelf registration statement that shall become effective upon filing with the SEC pursuant to Rule 462(e) if Rule 462(e)
is available to the Company) and (b) keep such Subsequent Shelf Registration Statement continuously effective and usable until the end
of the Effectiveness Period. Any such Subsequent Shelf Registration Statement shall be a registration statement on Form S-3 to the extent
that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration Statement shall be on another appropriate
form and shall provide for the registration of such Registrable Securities for resale by the Holders in accordance with any reasonable
method of distribution elected by the Sellers.


 


Section
1.4 Supplements and Amendments. The Company shall supplement and amend any Shelf Registration Statement if required by the Securities
Act or the rules, regulations or instructions applicable to the registration form used by the Company for such Shelf Registration Statement.


 


Section
1.5 Subsequent Holder Notice. If a Person entitled to the benefits of this Agreement becomes a Holder of Registrable Securities
after a Shelf Registration Statement becomes effective under the Securities Act, the Company shall as promptly as is reasonably practicable
following delivery of written notice to the Company of such Person becoming a Holder and requesting for its name to be included as a
selling security holder in the prospectus related to the Shelf Registration Statement (a “Subsequent Holder Notice”):


 


(a)
if required and permitted by applicable law, file with the SEC a supplement to the related prospectus or a post-effective amendment to
the Shelf Registration Statement so that such Holder is named as a selling security holder in the Shelf Registration Statement and the
related prospectus in such a manner as to permit such Holder to deliver a prospectus to purchasers of the Registrable Securities in accordance
with applicable law;


 


(b)
if, pursuant to Section 1.5(a), the Company shall have filed a post-effective amendment to the Shelf Registration Statement that
is not automatically effective, use its commercially reasonable efforts to cause such post-effective amendment to become effective under
the Securities Act as promptly as is reasonably practicable; and


 


(c)
notify such Holder as promptly as is reasonably practicable after the effectiveness under the Securities Act of any post-effective amendment
filed pursuant to Section 1.5(a).



 




    	4



    	 



    

 


Section
1.6 Underwritten Offering.


 


(a)
Subject to any applicable restrictions on transfer in the Purchase Agreement or otherwise, the Sellers may, after the Resale Shelf Registration
Statement becomes effective, deliver a written notice to the Company (the “Underwritten Offering Notice”) specifying
that the sale of some or all of the Registrable Securities subject to the Shelf Registration Statement is intended to be conducted through
an underwritten offering (the “Underwritten Offering”); provided, that the Holders of Registrable Securities
may not, without the Company’s prior written consent, (i) launch an Underwritten Offering the anticipated gross proceeds of which
shall be less than $2,500,000 (unless the Sellers are proposing to sell all of their remaining Registrable Securities), (ii) launch more
than three (3) Underwritten Offerings at the request of the Sellers within any twelve (12) month period or (iii) launch an Underwritten
Offering within the period commencing fourteen (14) days prior to and ending two (2) Business Days following the Company’s scheduled
earnings release date for any fiscal quarter or year (or such shorter period as is the Company’s customary “blackout window”
applicable to directors and officers) provided further, that any such Underwritten Offering may not be conducted if the “aggregate
worldwide market value” of the Company, as such term is defined in Section 12b-2 of the Securities Exchange Act of 1934, at the
time of proposed commencement of such an offering is less than $75 million.


 


(b)
In the event of an Underwritten Offering, the Sellers of a majority of the Registrable Securities participating in an Underwritten Offering
shall select the managing underwriter(s) to administer the Underwritten Offering; provided, that the choice of such managing underwriter(s)
shall be subject to the consent of the Company, which is not to be unreasonably withheld, conditioned or delayed. The Company and the
Holders of Registrable Securities participating in an Underwritten Offering will enter into an underwriting agreement in customary form
with the managing underwriter or underwriters selected for such offering.


 


(c)
The Company will not include in any Underwritten Offering pursuant to this Section 1.6 any securities that are not Registrable
Securities without the prior written consent of the Sellers. If the managing underwriter or underwriters advise the Company and the Sellers
in writing that in its or their good faith opinion the number of Registrable Securities (and, if permitted hereunder, other securities
requested to be included in such offering) exceeds the number of securities which can be sold in such offering in light of market conditions
or is such so as to adversely affect the success of such offering, the Company will include in such offering only such number of securities
that can be sold without adversely affecting the marketability of the offering, which securities will be so included in the following
order of priority: (i) first, the Registrable Securities of the Sellers that have requested to participate in such Underwritten Offering,
allocated pro rata among such Sellers on the basis of the percentage of the Registrable Securities then-owned by such Sellers,
(ii) second, the Persons party to the IFP Registration Rights Agreements that have the right to, and have requested, to participate in
such Underwritten Offering, allocated pro rata among such Persons on the basis of the percentage of the shares of registrable
Common Stock then-owned by such Persons and (iii) fourth, any other securities of the Company that have been requested to be so included.


 




    	5



    	 



    

 


Section
1.7 Take-Down Notice. Subject to the other applicable provisions of this Agreement, at any time that any Shelf Registration Statement
is effective, if the Sellers deliver a notice to the Company (a “Take-Down Notice”) stating that it intends to effect
a sale or distribution of all or part of its Registrable Securities included by it on any Shelf Registration Statement (a “Shelf
Offering”) and stating the number of the Registrable Securities to be included in such Shelf Offering, then the Company shall
amend, subject to the other applicable provisions of this Agreement or supplement the Shelf Registration Statement as may be necessary
in order to enable such Registrable Securities to be sold and distributed pursuant to the Shelf Offering.


 


Section
1.8 Piggyback Registration.


 


(a)
Subject to Section 1.8(b) below, from and after the Conversion Approval Date, neither the Company nor any of its security holders
(other than the Holders in such capacity pursuant hereto) may include securities of the Company in any registration statements other
than the Registrable Securities, other than pursuant to a Special Registration or securities registered pursuant to the IFP Registration
Rights Agreements.


 


(b)
The Company may conduct a registered public offering with respect to a primary offering of Common Stock (such offering, a “Primary
Offering”).


 


(c)
The Company shall give prompt written notice of the proposed filing of a registration statement (the “Primary Offering Registration
Statement”) for any Primary Offering, which notice shall be given, to the extent reasonably practicable, no later than ten
(10) Business Days prior to the filing date (the “Piggyback Notice”) to the Sellers. The Piggyback Notice shall offer
such Sellers the opportunity to include (or cause to be included) in such Primary Offering the number of shares of Registrable Securities
as each such Seller may request (each, a “Piggyback Transaction”). Subject to Section 1.8(d), the Company shall use
commercially reasonable efforts to include in each Piggyback Transaction all Registrable Securities with respect to which the Company
has received written requests for inclusion therein (each, a “Piggyback Request”) within five (5) Business Days after
the date of the Piggyback Notice but in any event not later than two (2) Business Day prior to the filing date of a Primary Offering
Registration Statement related to the Piggyback Transaction. The Company shall not be required to maintain the effectiveness of such
Primary Offering Registration Statement beyond the earlier of (x) 180 days after the effective date thereof and (y) consummation of the
distribution by the Sellers of the Registrable Securities included in such Primary Offering Registration Statement.


 


(d)
The Company shall use commercially reasonable efforts to cause the managing underwriter or underwriters of a proposed Primary Offering
to permit Sellers of Registrable Securities who have timely submitted a Piggyback Request in connection with such offering to include
in such offering all Registrable Securities included in each Seller’s Piggyback Request on the same terms and subject to the same
conditions as any other shares of capital stock, if any, of the Company included in the offering. Notwithstanding the foregoing, if the
managing underwriter or underwriters of such Primary Offering advise the Company in writing that in its or their good faith opinion the
number of securities exceeds the number of securities which can be sold in such offering in light of market conditions or is such so
as to adversely affect the success of such offering, the Company will include in such offering only such number of securities that can
be sold without adversely affecting the marketability of the offering, which securities will be so included in the following order of
priority: (A) first, the securities proposed to be sold by the Company for its own account; (B) second, the Registrable Securities of
the Sellers and IFP Sellers that have requested to participate in such Primary Offering, allocated pro rata among such Sellers and IFP
Sellers on the basis of their respective then-current ownership of Registrable Securities and IFP Registrable Securities; and (C) third,
any other securities of the Company that have been requested to be included in such offering; provided that the Sellers may, prior to
the time at which the offering price or underwriter’s discount is determined with the managing underwriter or underwriters, withdraw
their request to be included in such underwritten public offering pursuant to this Section 1.8.


 




    	6



    	 



    

 


Article
II


Additional
Provisions Regarding Registration Rights


 


Section
2.1 Registration Procedures. Subject to the other applicable provisions of this Agreement, in the case of each registration of
Registrable Securities effected by the Company pursuant to Article I, the Company shall:


 


(a)
prepare and promptly file with the SEC a registration statement with respect to such securities and use commercially reasonable efforts
to cause such registration statement to become and remain effective for the period of the distribution contemplated thereby, in accordance
with the applicable provisions of this Agreement;


 


(b)
prepare and file with the SEC such amendments (including post-effective amendments) and supplements to such registration statement and
the prospectus used in connection with such registration statement as may be necessary to keep such registration statement effective
for the period specified in paragraph (a) above and comply with the provisions of the Securities Act with respect to the disposition
of all securities covered by such registration statement in accordance with the Sellers’ intended method of distribution set forth
in such registration statement for such period;


 


(c)
furnish to the Sellers’ legal counsel copies of the registration statement and the prospectus included therein (including each
preliminary prospectus) proposed to be filed and provide such legal counsel a reasonable opportunity to review and comment on such registration
statement;


 


(d)
if requested by the managing underwriter or underwriters, if any, or the Sellers, promptly include in any prospectus supplement or post-effective
amendment such information as the managing underwriter or underwriters, if any, or the Sellers may reasonably request in order to permit
the intended method of distribution of such securities and make all required filings of such prospectus supplement or post-effective
amendment as soon as reasonably practicable after the Company has received such request;


 


(e)
if requested by the managing underwriter or underwriters, if any, or the Sellers, promptly include in any prospectus supplement or post-effective
amendment such information as the managing underwriter or underwriters, if any, or the Sellers may reasonably request in order to permit
the intended method of distribution of such securities and make all required filings of such prospectus supplement or post-effective
amendment as soon as reasonably practicable after the Company has received such request;


 


(f)
as promptly as is reasonably practicable notify the Sellers at any time when a prospectus relating thereto is required to be delivered
under the Securities Act or of the Company’s discovery of the occurrence of any event as a result of which the prospectus included
in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact
required to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances
then existing, and, subject to Section 2.2, at the request of the Sellers, prepare promptly and furnish to the Sellers a reasonable
number of copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers
of such securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein not misleading or incomplete in the light of the circumstances then
existing;


 




    	7



    	 



    

 


(g)
use commercially reasonable efforts to register and qualify (or exempt from such registration or qualification) the securities covered
by such registration statement under such other securities or “blue sky” laws of such jurisdictions within the United States
as shall be reasonably requested in writing by the Sellers; provided, however, that the Company shall not be required in
connection therewith or as a condition thereto to (i) qualify to do business in any jurisdictions where it would not otherwise be required
to qualify but for this subsection or (ii) take any action that would subject it to general service of process in any such jurisdictions;


 


(h)
in the event that the Registrable Securities are being offered in an underwritten public offering, enter into an underwriting agreement
in accordance with the applicable provisions of this Agreement;


 


(i)
in connection with an Underwritten Offering, the Company shall cause its officers to use their commercially reasonable efforts to support
the marketing of the Registrable Securities covered by such offering (including participation in “road shows” or other
similar marketing efforts);


 


(j)
use commercially reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters for sale,
if such securities are being sold through underwriters, (i) an opinion dated such date of the legal counsel representing the Company
for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public offering,
addressed to the underwriters, if any, (ii) a “negative assurances letter”, dated such date of the legal counsel representing
the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public
offering and (iii) a letter dated such date from the independent certified public accountants of the Company, in form and substance as
is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the
underwriters;


 


(k)
use commercially reasonable efforts to list the Registrable Securities covered by such registration statement with any securities exchange
on which the Common Stock is then listed;


 


(l)
provide a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration statement;


 


(m)
in connection with a customary due diligence review, make available for inspection by the Sellers, any underwriter participating in any
such disposition of Registrable Securities, if any, and any counsel or accountants retained by the Sellers or underwriter (collectively,
the “Offering Persons”), at the offices where normally kept, during reasonable business hours, all financial and other
records, pertinent corporate documents and properties of the Company and its subsidiaries, and cause the officers, directors and employees
of the Company and its subsidiaries to supply all information and participate in customary due diligence sessions in each case reasonably
requested by any such representative, underwriter, counsel or accountant in connection with such Registration Statement, provided,
however, that any information that is not generally publicly available at the time of delivery of such information shall be kept confidential
by such Offering Persons unless (i) disclosure of such information is required by court or administrative order or in connection with
an audit or examination by, or a blanket document request from, a regulatory or self-regulatory authority, bank examiner or auditor,
(ii) disclosure of such information, in the reasonable judgment of the Offering Persons, is required by law or applicable legal process
(including in connection with the offer and sale of securities pursuant to the rules and regulations of the SEC), (iii) such information
is or becomes generally available to the public other than as a result of a non-permitted disclosure or failure to safeguard by such
Offering Persons in violation of this Agreement or (iv) such information (A) was known to such Offering Persons or their representatives
from a source other than the Company when such source, to the knowledge of the Offering Persons, was not bound by any contractual, legal
or fiduciary obligation of confidentiality to the Company with respect to such information, (B) becomes available to the Offering Persons
from a source other than the Company when such source, to the knowledge of the Offering Persons, is not bound by any contractual, legal
or fiduciary obligation of confidentiality to the Company with respect to such information or (C) was developed independently by the
Offering Persons or their respective representatives without the use of, or reliance on, information provided by the Company;


 




    	8



    	 



    

 


(n)
cooperate with the Sellers and each underwriter or agent participating in the disposition of Registrable Securities and their respective
counsel in connection with any filings required to be made with FINRA, including the use of commercially reasonable efforts to obtain
FINRA’s pre-clearance or pre-approval of the registration statement and applicable prospectus upon filing with the SEC; and


 


(o)
as promptly as is reasonably practicable notify the Sellers (i) when the prospectus or any prospectus supplement or post-effective amendment
has been filed and, with respect to such registration statement or any post-effective amendment, when the same has become effective,
(ii) of any request by the SEC or other federal or state governmental authority for amendments or supplements to such registration statement
or related prospectus or to amend or to supplement such prospectus or for additional information, (iii) of the issuance by the SEC of
any stop order suspending the effectiveness of such registration statement or the initiation of any proceedings for such purpose, (iv)
if at any time the Company has reason to believe that the representations and warranties of the Company contained in any agreement (including
any underwriting agreement contemplated by Section 2.1(f) above) cease to be true and correct or (v) of the receipt by the Company
of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities
for sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose.


 


The
Sellers agree that, upon receipt of any notice from the Company of the happening of any event of the kind described in Sections ‎2.1(f),
‎2.1(o)(ii) or ‎2.1(o)(iii), the Sellers shall discontinue disposition of any Registrable Securities covered by
such registration statement or the related prospectus until receipt of the copies of the supplemented or amended prospectus, which supplement
or amendment shall, subject to the other applicable provisions of this Agreement, be prepared and furnished as soon as reasonably practicable,
or until the Sellers are advised in writing by the Company that the use of the applicable prospectus may be resumed, and have received
copies of any amended or supplemented prospectus or any additional or supplemental filings which are incorporated, or deemed to be incorporated,
by reference in such prospectus (such period during which disposition is discontinued being an “Interruption Period”)
and, if requested by the Company in writing, the Sellers shall use commercially reasonable efforts to return to the Company all copies
then in their possession, of the prospectus covering such Registrable Securities at the time of receipt of such request. As soon as is
reasonably practicable after the Company has determined that the use of the applicable prospectus may be resumed, the Company will notify
the Sellers thereof. In the event the Company invokes an Interruption Period hereunder and in the reasonable discretion of the Company
the need for the Company to continue the Interruption Period ceases for any reason, the Company shall provide written notice, as soon
as is reasonably practicable, to the Sellers that such Interruption Period is no longer applicable.


 




    	9



    	 



    

 


Section
2.2 Suspension. (a) The Company shall be entitled, on two (2) occasions in any 12-month
period, for a period of time not to exceed 60 days in the aggregate in any such 12-month period, to (x) defer any registration of Registrable
Securities and shall have the right not to file and not to cause the effectiveness of any registration covering any Registrable Securities,
(y) suspend the use of any prospectus and registration statement covering any Registrable Securities, and (z) require the Holders of
Registrable Securities to suspend any offerings or sales of Registrable Securities pursuant to a registration statement, if the Company
delivers to the Sellers a certificate signed by an executive officer certifying that such registration and offering would (i) require
the Company to make an Adverse Disclosure, (ii) materially interfere with any bona fide material financing, acquisition, disposition
or other similar transaction involving the Company or any of its subsidiaries then under consideration. Such certificate shall contain
a statement of the reasons for such suspension and the anticipated length of such suspension or (iii) during
the first month after the end of a fiscal quarter of the Company (i.e., January, April, July and October to the extent the Company’s
fiscal quarters end on December 31, March 31, June 30 and September 30) if, based on the good faith judgment of the Company, after consultation
with outside counsel to the Company, such postponement or suspension is necessary in order to avoid the premature disclosure of material
non-public information (including financial results for the preceding fiscal quarter) and the Company has a bona fide business purpose
for not disclosing such information publicly at that time. The Sellers shall keep the information contained in such certificate
confidential subject to the same terms set forth in Section 2.1(m). If the Company defers
any registration of Registrable Securities in response to a Underwritten Offering Notice,
or requires the Holders to suspend any Underwritten Offering, the Sellers shall be entitled
to withdraw such Underwritten Offering Notice and if they do so, such request shall not
be treated for any purpose as the delivery of an Underwritten Offering Notice pursuant to
Section 1.6.


 


Section
2.3 Expenses of Registration. All Registration Expenses incurred in connection with any registration shall be borne by the Company,
provided that each holder of Registrable Securities participating in an offering shall pay all applicable underwriting discounts
and commissions, brokers’ commissions and stock transfer taxes, if any, on the Registrable Securities sold by such holder and the
fees and expenses of any counsel to the Holders (other than such fees and expenses expressly included in Registration Expenses).


 


Section
2.4 Information by Holders. The Holder or Holders of Registrable Securities included in any registration shall furnish to the
Company such information regarding such Holder or Holders and their Affiliates, the Registrable Securities held by them and the distribution
proposed by such Holder or Holders and their Affiliates as the Company may reasonably request and as shall be required in connection
with any registration, qualification or compliance referred to in this Agreement. It is understood and agreed that the obligations of
the Company under Article I are conditioned on the timely provisions of the foregoing information by such Holder or Holders and,
without limitation of the foregoing, will be conditioned on compliance by such Holder or Holders with the following:


 


(a)
such Holder or Holders will, and will cause their respective Affiliates to, cooperate with the Company in connection with the preparation
of the applicable registration statement and prospectus and, for so long as the Company is obligated to keep such registration statement
effective, such Holder or Holders will and will cause their respective Affiliates to, provide to the Company, in writing and in a timely
manner, for use in such registration statement (and expressly identified in writing as such), all information regarding themselves and
their respective Affiliates and such other information as may be required by applicable law to enable the Company to prepare or amend
such registration statement, any related prospectus and any other documents related to such offering covering the applicable Registrable
Securities owned by such Holder or Holders and to maintain the currency and effectiveness thereof;


 




    	10



    	 



    

 


(b)
during such time as such Holder or Holders and their respective Affiliates may be engaged in a distribution of the Registrable Securities,
such Holder or Holders will, and they will cause their Affiliates to, comply with all laws applicable to such distribution, including
Regulation M promulgated under the Exchange Act, and, to the extent required by such laws, will, and will cause their Affiliates to,
among other things (i) not engage in any stabilization activity in connection with the securities of the Company in contravention of
such laws; (ii) distribute the Registrable Securities acquired by them solely in the manner described in the applicable registration
statement and (iii) if required by applicable law, cause to be furnished to each agent or broker-dealer to or through whom such Registrable
Securities may be offered, or to the offeree if an offer is made directly by such Holder or Holders or their respective Affiliates, such
copies of the applicable prospectus (as amended and supplemented to such date) and documents incorporated by reference therein as may
be required by such agent, broker-dealer or offeree;


 


(c)
such Holder or Holders shall, and they shall cause their respective Affiliates to, (i) permit the Company and its representatives to
examine such documents and records and will supply in a timely manner any information as they may be reasonably requested to provide
in connection with the offering or other distribution of Registrable Securities by such Holder or Holders and (ii) execute, deliver and
perform under any agreements and instruments reasonably requested by the Company or its representatives to effectuate such registered
offering, including opinions of counsel and questionnaires; and


 


(d)
on receipt of any notice from the Company of the occurrence of any of the events specified in Section 2.1(f) or clauses (ii)
or (iii) of Section 2.1(m), or that otherwise requires the suspension by such Holder or Holders and their respective
Affiliates of the offering, sale or distribution of any of the Registrable Securities owned by such Holder or Holders, such Holders shall,
and they shall cause their respective Affiliates to, cease offering, selling or distributing the Registrable Securities owned by such
Holder or Holders until the offering. sale and distribution of the Registrable Securities owned by such Holder or Holders may recommence
in accordance with the terms hereof and applicable law.


 


Section
2.5 Rule 144 Reporting. With a view to making available the benefits of Rule 144 to the Holders, the Company agrees that, for
so long as a Holder owns Registrable Securities, the Company will use its commercially reasonable efforts to:


 


(a)
make and keep public information available, as those terms are understood and defined in Rule 144, at all times after the date of this
Agreement; and


 


(b)
so long as a Holder owns any Registrable Securities, furnish to the Holder upon written request a written statement by the Company as
to its compliance with the reporting requirements of the Exchange Act.


 




    	11



    	 



    

 


Section
2.6 Plan of Distribution and Legal Counsel. The Sellers holding a majority of the Registrable Securities to be included in any
offering shall be entitled to determine the plan of distribution and to select counsel for the Sellers (which may be the same as counsel
for the Company).


 


Section
2.7 Lockup. In connection with any Underwritten Offering of Registrable Securities, (i) the Company (and each of its executive
officers and directors) and (ii) each Holder which is selling shares of Common Stock pursuant to its rights hereunder will agree to be
bound by the underwriting agreement’s lockup restrictions (which must apply, and continue to apply, in like manner to each of the
Company (and each of its executive officers and directors) and Holders participating in the Underwritten Offering) that are agreed to
by Holders holding a majority of shares being sold by all Holders in such Underwritten Offering.


 


Article
III


Indemnification


 


Section
3.1 Indemnification by Company. To the fullest extent permitted by applicable law, the Company will, with respect to any Registrable
Securities covered by a registration statement or prospectus, or as to which registration, qualification or compliance under applicable
“blue sky” laws has been effected pursuant to this Agreement, indemnify and hold harmless each Holder, each Holder’s
current and former officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents and employees, and
each Person controlling such Holder within the meaning of Section 15 of the Securities Act and such Holder’s current and former
officers, directors, partners, members, managers, shareholders, accountants, attorneys, agents and employees, and each underwriter thereof,
if any, and each Person who controls any such underwriter within the meaning of Section 15 of the Securities Act (collectively, the “Company
Indemnified Parties”), from and against any and all expenses, claims, losses, damages, costs (including costs of preparation
and reasonable attorney’s fees and any legal or other fees or expenses actually and reasonably incurred by such party in connection
with any investigation or proceeding), judgments, fines, penalties, charges, amounts paid in settlement and other liabilities, joint
or several (or actions in respect thereof) (collectively, “Losses”) to the extent arising out of or based on any untrue
statement (or alleged untrue statement) of a material fact contained in any registration statement, prospectus, preliminary prospectus,
offering circular, “issuer free writing prospectus” (as such term is defined in Rule 433 under the Securities Act) or other
document, in each case related to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged
omission) to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the
circumstances in which they were made, not misleading, or any violation by the Company of the Securities Act, the Exchange Act, any state
securities law or any rules or regulations thereunder applicable to the Company and (without limiting the preceding portions of this
Section 3.1), the Company will reimburse each of the Company Indemnified Parties for any reasonable and documented out-of-pocket
legal expenses and any other reasonable and documented out-of-pocket expenses actually incurred in connection with investigating, defending
or, subject to the last sentence of this Section 3.1, settling any such Losses or action, as such expenses are incurred; provided
that the Company’s indemnification obligations shall not apply to amounts paid in settlement of any Losses or action if such
settlement is effected without the prior written consent of the Company (which consent shall not be unreasonably withheld or delayed),
nor shall the Company be liable to a Holder in any such case for any such Losses or action to the extent that it arises out of or is
based upon a violation or alleged violation of any state or federal law (including any claim arising out of or based on any untrue statement
or alleged untrue statement or omission or alleged omission in the registration statement or prospectus) which occurs in reliance upon
and in conformity with written information regarding such Holder furnished to the Company by such Holder expressly for use in connection
with such registration by any such Holder.


 




    	12



    	 



    

 


Section
3.2 Indemnification by Holders. To the fullest extent permitted by applicable law, each Holder will, if Registrable Securities
held by such Holder are included in the securities as to which registration or qualification or compliance under applicable “blue
sky” laws is being effected, indemnify, severally and not jointly with any other Holders of Registrable Securities, the Company,
each of its Representatives, each Person who controls the Company or such underwriter within the meaning of Section 15 of the Securities
Act (collectively, the “Holder Indemnified Parties”), against all Losses (or actions in respect thereof) to the extent
arising out of or based on any untrue statement (or alleged untrue statement) of a material fact contained in any registration statement,
prospectus, preliminary prospectus, offering circular, “issuer free writing prospectus” or other document, in each case related
to such registration statement, or any amendment or supplement thereto, or based on any omission (or alleged omission) to state therein
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading, and will reimburse each of the Holder Indemnified Parties for any reasonable and documented out-of-pocket
legal expenses and any other reasonable and documented out-of-pocket expenses actually incurred in connection with investigating, defending
or, subject to the last sentence of this Section 3.2, settling any such Losses or action, as such expenses are incurred, in each
case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission)
is made in such registration statement, prospectus, offering circular, “issuer free writing prospectus” or other document
in reliance upon and in conformity with written information regarding such Holder furnished to the Company by such Holder and stated
to be specifically for use therein; provided, however, that in no event shall any indemnity under this Section
3.2 payable by any Holder exceed an amount equal to the net proceeds received by such Holder in respect of the Registrable Securities
sold pursuant to the registration statement. The indemnity agreement contained in this Section 3.2 shall not apply to amounts
paid in settlement of any loss, claim, damage, liability or action if such settlement is effected without the prior written consent of
the applicable Holder (which consent shall not be unreasonably withheld or delayed).


 


Section
3.3 Notification. If any Person shall be entitled to indemnification under this Article III (each, an “Indemnified
Party”), such Indemnified Party shall give prompt notice to the party required to provide indemnification (each, an “Indemnifying
Party”) of any claim or of the commencement of any proceeding as to which indemnity is sought. The Indemnifying Party shall
have the right, exercisable by giving written notice to the Indemnified Party as promptly as is reasonably practicable after the receipt
of written notice from such Indemnified Party of such claim or proceeding, to assume, at the Indemnifying Party’s expense, the
defense of any such claim or litigation, with counsel reasonably satisfactory to the Indemnified Party and, after notice from the Indemnifying
Party to such Indemnified Party of its election to assume the defense thereof, the Indemnifying Party will not (so long as it shall continue
to have the right to defend, contest, litigate and settle the matter in question in accordance with this paragraph) be liable to such
Indemnified Party hereunder for any legal expenses and other expenses subsequently incurred by such Indemnified Party in connection with
the defense thereof; provided, however, that an Indemnified Party shall have the right to employ separate counsel in any such claim or
litigation, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party unless the Indemnifying Party
shall have failed within a reasonable period of time to assume such defense and the Indemnified Party is or would reasonably be expected
to be materially prejudiced by such delay. The failure of any Indemnified Party to give notice as provided herein shall relieve an Indemnifying
Party of its obligations under this Article III only to the extent that the failure to give such notice is materially prejudicial
or harmful to such Indemnifying Party’s ability to defend such action. No Indemnifying Party, in the defense of any such claim
or litigation, shall, except with the prior written consent of each Indemnified Party (which consent shall not be unreasonably withheld
or delayed), consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation.
The indemnity agreements contained in this Article III shall not apply to amounts paid in settlement of any claim, loss, damage,
liability or action if such settlement is effected without the prior written consent of the Indemnifying Party, which consent shall not
be unreasonably withheld or delayed. The indemnification set forth in this Article III shall be in addition to any other indemnification
rights or agreements that an Indemnified Party may have. An Indemnifying Party who is not entitled to, or elects not to, assume the defense
of a claim will not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such Indemnifying
Party with respect to such claim, unless in the reasonable judgment of any Indemnified Party a conflict of interest may exist between
such Indemnified Party and any other Indemnified Parties with respect to such claim.


 




    	13



    	 



    

 


Section
3.4 Contribution. If the indemnification provided for in this Article III is held by a court of competent jurisdiction
to be unavailable to an Indemnified Party, other than pursuant to its terms, with respect to any Losses or action referred to therein,
then, subject to the limitations contained in this Article III, the Indemnifying Party, in lieu of indemnifying such Indemnified
Party hereunder, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses or action in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party, on the one hand, and the Indemnified Party, on
the other, in connection with the actions, statements or omissions that resulted in such Losses or action, as well as any other relevant
equitable considerations. The relative fault of the Indemnifying Party, on the one hand, and the Indemnified Party, on the other hand,
shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement
of a material fact or omission or alleged omission to state a material fact, has been made (or omitted) by, or relates to information
supplied by such Indemnifying Party or such Indemnified Party, and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent any such action, statement or omission. The Company and the Holders agree that it would not be
just and equitable if contribution pursuant to this Section 3.4 was determined solely upon pro rata allocation or by any other
method of allocation which does not take account of the equitable considerations referred to in the immediately preceding sentence of
this Section 3.4. Notwithstanding the foregoing, the amount any Holder will be obligated to contribute pursuant to this Section 3.4 will
be limited to an amount equal to the net proceeds received by such Holder in respect of the Registrable Securities sold pursuant to the
registration statement which gives rise to such obligation to contribute. No Person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation.


 


Section
3.5 Survival. The indemnification provided for under this Article III shall survive the sale or other transfer of the Registrable
Securities and the termination of this Agreement.


 


Article
IV


Transfer
and Termination of Registration Rights


 


Section
4.1 Transfer of Registration Rights. Any rights to cause the Company to register securities granted to a Holder under this Agreement
may be transferred or assigned to any Person in connection with a transfer permitted by the Purchase Agreement; provided, however,
that (i) prior written notice of such assignment of rights is given to the Company, and (ii) such transferee agrees in writing to be
bound by, and subject to, this Agreement as a “Holder” pursuant to a written instrument in the form of Exhibit
B hereto.


 




    	14



    	 



    

 


Section
4.2 Termination of Registration Rights. The rights of any particular Holder to cause the Company to register securities under
Article I shall terminate with respect to such Holder upon the date upon which such Holder no longer holds any Registrable Securities.
The registration rights set forth in this Agreement shall terminate on the date on which all shares of Common Stock issuable (or actually
issued) upon conversion of the Company Convertible Preferred Stock or upon exercise of the Warrants cease to be Registrable Securities.


 


Article
V


Miscellaneous


 


Section
5.1 Amendments and Waivers. Subject to compliance with applicable law, this Agreement may be amended or supplemented in any and
all respects by written agreement of the Company and the Sellers.


 


Section
5.2 Extension of Time, Waiver, Etc. The parties hereto may, subject to applicable law, (a) extend the time for the performance
of any of the obligations or acts of the other party or (b) waive compliance by the other party with any of the agreements contained
herein applicable to such party or, except as otherwise provided herein, waive any of such party’s conditions. Notwithstanding
the foregoing, no failure or delay by the parties hereto in exercising any right hereunder shall operate as a waiver thereof nor shall
any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right hereunder. Any
agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing
signed on behalf of such party.


 


Section
5.3 Assignment. Except as provided in Section 4.1, neither this Agreement nor any of the rights, interests or obligations
hereunder shall be assigned, in whole or in part, by operation of law or otherwise, by any of the parties hereto without the prior written
consent of the other party hereto.


 


Section
5.4 Counterparts. This Agreement may be executed in one or more counterparts (including by facsimile or electronic mail), each
of which shall be deemed to be an original but all of which taken together shall constitute one and the same agreement, and shall become
effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto.


 


Section
5.5 Entire Agreement; No Third Party Beneficiary. This Agreement, including the Transaction Documents, constitutes the entire
agreement, and supersedes all other prior agreements and understandings, both written and oral, among the parties and their Affiliates,
or any of them, with respect to the subject matter hereof and thereof. No provision of this Agreement shall confer upon any Person other
than the parties hereto and their permitted assigns any rights or remedies hereunder.


 


Section
5.6 Governing Law; Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Agreement
shall be determined in accordance with the provisions of the Purchase Agreement.


 




    	15



    	 



    

 


Section
5.7 Specific Enforcement. The parties acknowledge and agree that (a) the parties shall be entitled to an injunction or injunctions,
specific performance or other equitable relief to enforce specifically the terms and provisions hereof in the courts described in Section
5.6 without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement
and (b) the right of specific enforcement is an integral part of this Agreement and without that right, neither the Company nor the Sellers
would have entered into this Agreement. The parties hereto agree not to assert that a remedy of specific enforcement is unenforceable,
invalid, contrary to law or inequitable for any reason, and agree not to assert that a remedy of monetary damages would provide an adequate
remedy or that the parties otherwise have an adequate remedy at law. The parties hereto acknowledge and agree that any party seeking
an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
in accordance with this Section 5.7 shall not be required to provide any bond or other security in connection with any such order
or injunction.


 


Section
5.8 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH
PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE,
THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) IT UNDERSTANDS AND HAS CONSIDERED
THE IMPLICATIONS OF SUCH WAIVER, (C) IT MAKES SUCH WAIVER VOLUNTARILY AND (D) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 5.8.


 


Section
5.9 Notices. All notices, requests and other communications to any party hereunder shall be in writing and shall be deemed given
if delivered personally, emailed (which is confirmed) or sent by overnight courier (providing proof of delivery) to the parties at the
following addresses:


 


(a)
If to Sellers or Sellers’ Representatives:


 


See
signature page to Purchase Agreement.


With
copies (which shall not constitute notice) to:


 


See
signature page to Purchase Agreement.


 


(b)
If to Company:


Intelligent
Bio Solutions Inc.


142
West 57th Street, 11th Floor


New
York, NY 10019


Attn:
Spiro Sakiris


Email:
spiro.sakiris@ibs.inc


 




    	16



    	 



    

 


With
a copy (which shall not constitute notice) to:


 


Arent
Fox Schiff LLP


1717
K Street NW, Washington, DC 20006


Attn:
Ralph De Martino and Johnathan Duncan


Email:
ralph.demartino@afslaw.com and


johnathan.duncan@afslaw.com


 


or
such other address or email address as such party may hereafter specify by like notice to the other parties hereto. All such notices,
requests and other communications shall be deemed received on the date of actual receipt by the recipient thereof if received prior to
5:00 p.m. local time in the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such notice, request
or communication shall be deemed not to have been received until the next succeeding Business Day in the place of receipt.


 


Section
5.10 Severability. If any term, condition or other provision of this Agreement is determined by a court of competent jurisdiction
to be invalid, illegal or incapable of being enforced by any rule of law or public policy, all other terms, provisions and conditions
of this Agreement shall nevertheless remain in full force and effect. Upon such determination that any term, condition or other provision
is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to
effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable law.


 


Section
5.11 Expenses. Except as provided in Section 2.3, all costs and expenses, including fees and disbursements of counsel,
financial advisors and accountants, incurred in connection with this Agreement and the transactions contemplated hereby shall be paid
by the party incurring such costs and expenses.


 


[Signature
pages follow]


 




    	17



    	 



    

 


IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first above written.


 


	 	COMPANY:
	 	 
	 	INTELLIGENT
    BIO SOLUTIONS INC.
	 	 	 
	 	By:	 
	 	Name:	Spiro
    Sakiris
	 	Title:	Chief
    Financial Officer


 


Signature
Page to Registration Rights Agreement


 




    	18



    	 



    

 


	SELLER:	 
	 	 	 
	By:	    	 
	Name:	 	 
	Title:	 	 


 


SIGNATURE
PAGE TO REGISTRATION RIGHTS AGREEMENT


 




    	19



    	 



    

 


EXHIBIT
A


DEFINED
TERMS


 


Capitalized
terms used and not defined herein shall have the meanings set forth in the Purchase Agreement.


 


1.
The following capitalized terms have the meanings indicated:


 


“Adverse
Disclosure” means public disclosure of material non-public information that, in the good faith judgment of the Company (after
consultation with external legal counsel): (i) would be required to be made in any registration statement filed with the SEC by the Company
so that such registration statement would not be materially misleading; (ii) would not be required to be made at such time but for the
filing, effectiveness or continued use of such registration statement; and (iii) the Company has a bona fide business purpose for not
disclosing publicly.


 


“Affiliates”
shall have the meaning given to such term in the Purchase Agreement.


 


“Business
Day” shall have the meaning given to such term in the Purchase Agreement.


 


“Certificate
of Designation” means the Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred
Stock.


 


“Common
Stock” means all shares currently or hereafter existing of the Company’s common stock, par value $0.01 per share.


 


“Conversion
Approval” shall have the meaning given to such term in the Certificate of Designation.


 


“Conversion
Approval Date” the date on which the Conversion Approval has been duly obtained.


 


“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and any successor statute thereto, and the rules and regulations
of the SEC promulgated thereunder.


 


“FINRA”
means the Financial Industry Regulatory Authority, Inc.


 


“Holder”
means any Person holding Registrable Securities.


 


“IFP”
means Intelligent Fingerprinting Limited, a company registered in England and Wales.


 


“IFP
Registration Rights Agreements” means the two separate Registration Rights Agreements, each dated October 4, 2022, by and among
the Company and the IFP Sellers listed on Annex A and Annex B thereto, which were entered into in connection with the Company’s
acquisition of IFP.


 


“IFP
Registrable Securities” means “Registrable Securities” as defined under the IFP Registration Rights Agreements.


 




    	20



    	 



    

 


“IFP
Sellers” means the Persons from which the Company acquired all the issued and outstanding shares of IFP pursuant a Share Exchange
Agreement with the Company in a transaction that closed on October 4, 2022.


 


“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.


 


“register”,
“registered” and “registration” refer to a registration effected by preparing and filing a registration
statement in compliance with the Securities Act, and the declaration or ordering of the effectiveness of such registration statement
or the automatic effectiveness of such registration statement, as applicable.


 


“Registration
Expenses” means all expenses incurred by the Company in complying with Article I, including all registration, qualification,
listing and filing fees, printing expenses, escrow fees, fees and disbursements of counsel and accountants, fees and expenses in connection
with complying with state securities or “blue sky” laws, FINRA fees, fees of transfer agents and registrars, transfer taxes,
and fees and expenses of one outside legal counsel to the Sellers and all Holders retained in connection with registrations contemplated
hereby, but excluding underwriting discounts and commissions, brokers’ commissions and stock transfer taxes, if any, in each case
to the extent applicable to the Registrable Securities of any selling Holders.


 


“Registrable
Securities” means, as of any date of determination, any shares of Common Stock acquired by any Sellers pursuant to the conversion
of any Company Convertible Preferred Stock and the exercise of the Warrants, and any other securities issued or issuable with respect
to any such shares of Common Stock by way of share split, share dividend, distribution, recapitalization, merger, exchange, replacement
or similar event or otherwise. As to any particular Registrable Securities, once issued, such securities shall cease to be Registrable
Securities when (i) such securities are sold or otherwise transferred pursuant to an effective Registration Statement under the Securities
Act, (ii) such securities shall have ceased to be outstanding, (iii) such securities have been transferred in a transaction in which
the Holder’s rights under this Agreement are not assigned to the transferee of the securities or (iv) such securities are sold
in a broker’s transaction under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions
then in force) under the Securities Act are met.


 


“Reverse
Split Approval” shall have the meaning given to such term in the Certificate of Designation.


 


“Reverse
Split Approval Date” the date on which the Reverse Split Approval has been duly obtained.


 


“Rule
144” means Rule 144 promulgated under the Securities Act and any successor provision.


 


“Rule
462(e)” means Rule 462(e) promulgated under the Securities Act and any successor provision.


 


“SEC”
means the U.S. Securities and Exchange Commission.


 


“Securities
Act” means the Securities Act of 1933, as amended, and any successor statute thereto, and the rules and regulations of the
SEC promulgated thereunder.


 


“Shelf
Registration Statement” means the Resale Shelf Registration Statement or a Subsequent Shelf Registration Statement, as applicable.


 


“Special
Registration” means the registration of equity securities, options or similar rights registered on Form S-4, Form S-8 or any
successor forms thereto or any other form for the registration of securities issued or to be issued
in connection with a merger, acquisition, employee benefit plan or equity compensation or incentive plan.


 


“Transaction
Documents” shall have the meaning given to such term in the Purchase Agreement.


 





 




    	21



    	 



    

 


2.
The following terms are defined in the Sections of the Agreement indicated:


 


INDEX
OF TERMS


 


	Term	 	Section
	 	 	 
	Actions	 	Section
    5.6(b)
	Agreement	 	Preamble
	Common
    Stock	 	Recitals
	Company	 	Preamble
	Company
    Convertible Preferred Stock	 	Recitals
	Company
    Indemnified Parties	 	Section
    3.1
	Effectiveness
    Period	 	Section
    1.2
	Filing
    Date	 	Section
    1.1
	Holder
    Indemnified Parties	 	Section
    3.2
	Indemnified
    Party	 	Section
    3.3
	Indemnifying
    Party	 	Section
    3.3
	Interruption
    Period	 	Section
    2.1(m)
	Purchase
    Agreement	 	Recitals
	Losses	 	Section
    3.1
	Offering
    Persons	 	Section
    2.1(k)
	Other
    IFP Sellers	 	Preamble
	Resale
    Shelf Registration Statement	 	Section
    1.1
	 	 	 
	Sellers	 	Preamble
	Shelf
    Offering	 	Section
    1.7
	Subsequent
    Holder Notice	 	Section
    1.5
	Subsequent
    Shelf Registration Statement	 	Section
    1.3
	Take-Down
    Notice	 	Section
    1.
	Underwritten
    Offering	 	Section
    1.6(a)
	Underwritten
    Offering Notice	 	Section
    1.6(a)
	Warrants	 	Recitals


 




    	22



    	 



    

 


EXHIBIT
B


JOINDER
TO REGISTRATION RIGHTS AGREEMENT


 


The
undersigned is executing and delivering this Joinder pursuant to the Registration Rights Agreement, dated as of December 21, 2022 (the
“Registration Rights Agreement”), by and between Intelligent Bio Solutions Inc. (the “Company”)
and the sellers listed on the signature pages thereto (the “Investor”). Capitalized terms used and not defined herein shall
have the meanings set forth in the Registration Rights Agreement.


 


By
executing and delivering this Joinder to the Company, the undersigned hereby agrees to become a party to, to be bound by, and to comply
with the provisions of the Registration Rights Agreement as a Holder and an Seller as of the date hereof in the same manner as if the
undersigned were an original signatory to the Registration Rights Agreement.


 


Accordingly,
the undersigned has executed and delivered this Joinder as of [●], 20[●].


 


	 	[HOLDER]
	 	 	       
	 	By:	 
	 	Name:	 
	 	Title:	 


 




    	B-1



    	 



    

 


Annex
A





Sellers


 


	Seller
    Name	 	Seller
    Address
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 


 




    	A-1